Buerger's disease or obliterating thromboangiitis is an inflammatory pathologic condition affecting the distal vascular segments; it strikes young adults, especially males and heavy smokers. Medical and surgical treatment often fail to heal these patients, especially considering the frequent relapse of this disease linked with tobacco abuse—definitive healing often involves limb amputation. Electrical spinal cord stimulation is evaluated in this study with an analgesic aim and for improvement in skin microcirculation, with the goal of long-term healing of diseased limbs.
Get full access to this article
View all access options for this article.
References
1.
Buerger L.: Thromboangiitis obliterans: A study of the vascular lesion leading to presenile spontaneous gangrene. Am J Med Sci136:567-580, 1908.
2.
Wessler S., Ming SC, Gurewich V.: A critical evaluation of thromboangiitis obliterans. The case against Buerger's disease. N Engl J Med262:1149, 1960 .
3.
McMusick VA, Harris WS, Ottesen OE: Buerger's disease : A distinct clinical and pathologic entity. Am J Med Assoc181:93, 1962.
4.
Mishima Y.: Thromboangiitis obliterans (Buerger's disease). Int J Cardiol54(suppl):155, 1996.
5.
Shionoya S.: Buerger's Disease. Nagoya, Japan: The University of Nagoya Press, 1990.
6.
Nunez GA, Lopez CL, Rico ZL, et al: Thromboangiitis obliterans (Buerger's disease) with intestinal involvement. A case report. Angiology49:489-492, 1998.
7.
Swigris JJ, Olin JW, Mekhail NA: Implantable spinal cord stimulator to treat the ischemic manifestations of thromboangiitis obliterans (Buerger's disease). J Vasc Surg79:928-935, 1999.
8.
Olin JW, Yong JR, Graor RA, et al: The changing clinical and pathologic entity. Am J Med Assoc181:93, 1962.
9.
Lie JT: The rise and fall and resurgence of thromboangiitis obliterans (Buerger's disease). Acta Pathol Jpn39:153-158, 1989.
10.
Gulati SM, Madhra K., Thusoo TK, et al: Auto-antibodies in thromboangiitis obliterans (Buerger's disease) . Angiology33:642-651, 1982.
11.
Roncon R., Delgado L., Correia P., et al: Circulating immune complexes in Buerger's disease. J Cardiovasc Surg30:821-825, 1989.
12.
Papa M., Bass A., Adar R., et al: Autoimmune mechanisms in thromboangiitis obliterans (Buerger's disease): The role of tobacco antigen and the major histocompatibility complex . Surgery11:527-531, 1992.
13.
Tanaka K.: Pathology and pathogenesis of Buerger's disease. Int J Cardiol66(suppl 1):S237-S242, 1998.
14.
Fiessinger JN, Schafer N., for the TAO Study : Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. Lancet335: 555-557, 1990.
15.
The European TAO Study Group: Oral iloprost in the treatment of thromboangiitis obliterans (Buerger's disease): A double-blind, randomised, placebo-controlled trial. Eur J Vasc Endovasc Surg15:300-307, 1998.
16.
Nakajima N. : The change in concept and surgical treatment of Buerger's disease: Personal experience and review. Int J Cardiol66(suppl I):S273-S280, 1998.
17.
Sasajima T. , Kubo Y., Inaba M., et al: Role of infrainguinal bypass in Buerger's disease: An eighteen-year experience. Eur J Vasc Endovasc Surg13:186-192, 1997.
18.
Gordon A., Zechmeister K., Collin J.: The role of sympathectomy in current surgical practice. Eur J Vasc Surg8:129-137, 1994.
19.
Cousins MJ, Reeve TS, Glynn CJ, et al: Neurolytic lumbar sympathectomy: Duration of denervation and relief of rest pain. Anaesth Intensive Care7:121-135, 1979.
20.
McLoughlin GA, Helsby CR, Evans CC, et al: Association of HLA-A9 and HLA-B5 with Buerger's disease. Br J Med2:1165-1166, 1976.
21.
Gybels J., Erdine S., Maeyaert J., et al: Neuromodulation of pain. Eur J Pain2:203-209, 1998.
22.
Mills J.: Buerger's disease. Current status. Vasc Med Rev5:139-150, 1994.
23.
Nielubowicz J., Rosnowski A., Pruszynski B., et al: Natural history of Buerger's disease . J Cardiovasc Surg ( Torino) 529-540, 1980.
Kobayashi M. , Masafumi Ito, Nakagawa A., et al: Immunohistochemical analysis of arterial wall cellular infiltration in Buerger's disease (endarteritis obliterans) . J Vasc Surg29:451-458, 1999.
26.
Wysokinski W., Kwiatkowska W., Maslowski L., et al: Buerger's disease in two brothers: Iliac artery occlusion by thromboangiitis obliterans: Case report. Angiology49:409-414, 1998.
27.
Augustinsson LE: Anatomic effects of electric stimulation . Appl Neurophysiol45:185-189, 1982.
28.
Linderoth B. , Stiller CO, Gunasekera L., et al: Gamma-aminobutyric acid is released in the dorsal horn by electrical spinal cord stimulation: An in vivo micro-dialysis study in the rat. Neurosurgery34:484-488, 1994.
29.
Melzak R., Wall PD: Evolution of pain theories. Int Anesthesiol Clin8:3-34, 1970.
30.
Jacobs Mjhm , Jorning Pjg, Beckers Rcy, et al: Foot salvage and improvement of microvascular blood flow as a result of epidural spinal cord electrical stimulationJ Vasc Surg12:354-360, 1990.
31.
Mills JL: Buerger's disease: Current status. Vasc Med Rev5:139-150, 1994.
32.
Augustinsson LE, Holm J., Carlsson CA, et al: Epidural electrical stimulation in severe ischaemia. Evidence of pain relief, increased blood flow and possible limb saving effect. Ann Surg202:104-111, 1985.
33.
Tallis RC, Illis ES, Sedgwick EM, et al: Spinal cord stimulation in peripheral vascular disease. J Neurol Neurosurg Psychol46:478-484, 1983.
